Dont miss APIS presenting at Precision Oncology Europe - ‘Advantages of Using Clickmer Technology for the Detection of Biomarkers’

Dr. Nora Karnowski’s presentation will outline the advantages of Clickmer technology and how they can support biomarker development:

Clickmers are modified DNA aptamers that bind to their biomarker targets with nanomolar affinity. They can be developed within weeks, have high specificity and can be quantified using enzymatic, fluorescent, or qPCR readout for improved sensitivity.

The APIS Breast Cancer Subtyping Kit is a highly reproducible, RT-qPCR based IVD product (in certain territories) and RUO product for detecting standard (HER2, ER, PR, Ki67) and novel proliferative biomarkers.

The APIS ESR1 Mutations Kit is an advanced qPCR assay for the sensitive and precise detection of mutations within the oestrogen receptor gene. The kit has a wide target coverage of 11 different ESR1 mutations.

Use this link to contact us and schedule a meeting.